Longitudinal trends in health-related quality of life (HRQoL) among patients treated with ivosidenib (IVO) for IDH1-mutated cholangiocarcinoma (CCA) in the ClarIDHy study Meeting Abstract


Authors: Chamberlain, C. X.; Hua, Z. W.; Gliser, C.; Pandya, S. S.; Zhu, A. X.; Abou-Alfa, G. K.
Abstract Title: Longitudinal trends in health-related quality of life (HRQoL) among patients treated with ivosidenib (IVO) for IDH1-mutated cholangiocarcinoma (CCA) in the ClarIDHy study
Meeting Title: 2022 ASCO Gastrointestinal Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 40
Issue: 4 Suppl.
Meeting Dates: 2022 Jan 20-22
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2022-02-01
Language: English
ACCESSION: WOS:000770995900374
DOI: 10.1200/JCO.2022.40.4_suppl.388
PROVIDER: wos
Notes: Meeting Abstract: 388 -- Meeting was conducted online as well as in person -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ghassan Abou-Alfa
    568 Abou-Alfa